Table 1.
Cases | Controls | |||
---|---|---|---|---|
N | (%) | N | (%) | |
Age (years) | ||||
20–34 | 182 | (24.3) | 125 | (30.9) |
35–39 | 285 | (38.0) | 142 | (35.1) |
40–44 | 128 | (17.1) | 77 | (19.0) |
45–49 | 155 | (20.7) | 61 | (15.1) |
Any first-degree relative with breast cancer | ||||
No | 661 | (88.1) | 379 | (93.6) |
Yes | 89 | (11.9) | 26 | (6.4) |
Age at menarche (years) | ||||
<12 | 148 | (19.7) | 66 | (16.3) |
12 | 148 | (19.7) | 98 | (24.2) |
13 | 231 | (30.8) | 113 | (27.9) |
≥14 | 218 | (29.1) | 128 | (31.6) |
Missing | 5 | (0.7) | 0 | (0.0) |
Age at first live birth (years) | ||||
<20 | 50 | (6.7) | 31 | (7.7) |
20–24 | 162 | (21.6) | 86 | (21.2) |
25–29 | 225 | (30.0) | 109 | (26.9) |
≥30 | 128 | (17.1) | 64 | (15.8) |
No live birth | 185 | (24.7) | 115 | (28.4) |
Estrogen receptor status | ||||
Negative | 155 | (20.7) | ||
Positive | 261 | (34.8) | ||
Missing | 334 | (44.5) | ||
Progesterone receptor status | ||||
Negative | 118 | (15.7) | ||
Positive | 298 | (39.7) | ||
Missing | 334 | (44.5) |